Investors Grab CHRS Even Cheaper Than Its Secondary Stock Offering
June 27, 2018 at 16:16 PM EDT
Looking back to 36 days ago, Coherus BioSciences Inc (CHRS) priced a 5,172,413 share secondary stock offering at $14.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..